<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Compacting Bulk Drugs Classified as Manufacturing under Exim Policy, Benefiting Assessees with Advance Licenses for Deemed Exports.</title>
    <link>https://www.taxtmi.com/highlights?id=21909</link>
    <description>Advance license for deemed export - Compacting process of bulk drugs is a manufacturing process or not - The definition of &amp;#39;manufacture&amp;#39; of the Exim Policy is very wide - prima facie is in favor of assessee - AT</description>
    <language>en-us</language>
    <pubDate>Mon, 23 Feb 2015 06:03:43 +0530</pubDate>
    <lastBuildDate>Mon, 23 Feb 2015 06:03:43 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=376742" rel="self" type="application/rss+xml"/>
    <item>
      <title>Compacting Bulk Drugs Classified as Manufacturing under Exim Policy, Benefiting Assessees with Advance Licenses for Deemed Exports.</title>
      <link>https://www.taxtmi.com/highlights?id=21909</link>
      <description>Advance license for deemed export - Compacting process of bulk drugs is a manufacturing process or not - The definition of &amp;#39;manufacture&amp;#39; of the Exim Policy is very wide - prima facie is in favor of assessee - AT</description>
      <category>Highlights</category>
      <law>Customs</law>
      <pubDate>Mon, 23 Feb 2015 06:03:43 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/highlights?id=21909</guid>
    </item>
  </channel>
</rss>